补充维生素促进大肠杆菌治疗性纳米体的产生

IF 3.7 3区 生物学 Q2 BIOTECHNOLOGY & APPLIED MICROBIOLOGY
Richa Katiyar , Neha Gindi , Ishika Mittal , Claire Komives , Anurag S. Rathore
{"title":"补充维生素促进大肠杆菌治疗性纳米体的产生","authors":"Richa Katiyar ,&nbsp;Neha Gindi ,&nbsp;Ishika Mittal ,&nbsp;Claire Komives ,&nbsp;Anurag S. Rathore","doi":"10.1016/j.bej.2025.109887","DOIUrl":null,"url":null,"abstract":"<div><div>As low yields of nanobodies in <em>E.coli.</em> periplasm is a major concern for their large-scale production, this study explores the use of vitamins for enhanced production of a recombinant periplasmic nanobody product. Nanobody producing <em>E.coli</em> cells were cultivated in the modified Terrific-Broth supplemented with three different vitamins (biotin denoted as B, cyanocobalamin as C, and D-calcium pantothenate as P). Multiple combinations (B+P, B+C, P + C, and B+P + C) were examined, with B+P offering the highest specific growth rate, total biomass productivity, product accumulation and product expression. Densitometry analysis revealed 129.17 ± 1.1 mg/L nanobodies in case of B+P supplementation (24 % higher than control). B+P supplementation also offered 21 % better fermentation yield than control (as per RP-HPLC). The yield of purified nanobody product in case of B+P supplementation was at 35.0 ± 2.1 mg/L with purity levels of ≥ 80 %. Intact mass and peptide mapping analysis of purified nanobody revealed molecular weight of 15.2 kDa and 91 % sequence coverage with the theoretical nanobody sequence respectively. Spent media analysis revealed production of low acetate in case of B+P supplementation of media when compared to other conditions examined. Hence, the B+P supplementation could be used to produce improved amount of periplasmic nanobody in future.</div></div>","PeriodicalId":8766,"journal":{"name":"Biochemical Engineering Journal","volume":"223 ","pages":"Article 109887"},"PeriodicalIF":3.7000,"publicationDate":"2025-07-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Vitamin supplementation for enhanced production of therapeutic nanobody in E.coli\",\"authors\":\"Richa Katiyar ,&nbsp;Neha Gindi ,&nbsp;Ishika Mittal ,&nbsp;Claire Komives ,&nbsp;Anurag S. Rathore\",\"doi\":\"10.1016/j.bej.2025.109887\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>As low yields of nanobodies in <em>E.coli.</em> periplasm is a major concern for their large-scale production, this study explores the use of vitamins for enhanced production of a recombinant periplasmic nanobody product. Nanobody producing <em>E.coli</em> cells were cultivated in the modified Terrific-Broth supplemented with three different vitamins (biotin denoted as B, cyanocobalamin as C, and D-calcium pantothenate as P). Multiple combinations (B+P, B+C, P + C, and B+P + C) were examined, with B+P offering the highest specific growth rate, total biomass productivity, product accumulation and product expression. Densitometry analysis revealed 129.17 ± 1.1 mg/L nanobodies in case of B+P supplementation (24 % higher than control). B+P supplementation also offered 21 % better fermentation yield than control (as per RP-HPLC). The yield of purified nanobody product in case of B+P supplementation was at 35.0 ± 2.1 mg/L with purity levels of ≥ 80 %. Intact mass and peptide mapping analysis of purified nanobody revealed molecular weight of 15.2 kDa and 91 % sequence coverage with the theoretical nanobody sequence respectively. Spent media analysis revealed production of low acetate in case of B+P supplementation of media when compared to other conditions examined. Hence, the B+P supplementation could be used to produce improved amount of periplasmic nanobody in future.</div></div>\",\"PeriodicalId\":8766,\"journal\":{\"name\":\"Biochemical Engineering Journal\",\"volume\":\"223 \",\"pages\":\"Article 109887\"},\"PeriodicalIF\":3.7000,\"publicationDate\":\"2025-07-29\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Biochemical Engineering Journal\",\"FirstCategoryId\":\"5\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1369703X2500261X\",\"RegionNum\":3,\"RegionCategory\":\"生物学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"BIOTECHNOLOGY & APPLIED MICROBIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biochemical Engineering Journal","FirstCategoryId":"5","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1369703X2500261X","RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

大肠杆菌中纳米体的低产量。周质是其大规模生产的一个主要问题,本研究探索了使用维生素来增强重组周质纳米体产品的生产。产生纳米体的大肠杆菌细胞在添加了三种不同维生素(生物素表示为B,氰钴胺素表示为C,泛酸d -钙表示为P)的改良Terrific-Broth中培养。对B+P、B+C、P + C和B+P + C组合进行了研究,结果表明,B+P组合的特定生长率、总生物量、产物积累和产物表达量最高。密度分析显示,添加B+P组产生129.17个 ± 1.1 mg/L纳米体(比对照组高24 %)。B+P的发酵产率也比对照提高了21% % (RP-HPLC)。添加B+P后,纳米体的产率为35.0 ± 2.1 mg/L,纯度≥ 80 %。对纯化的纳米体进行完整质量和多肽图谱分析,结果显示分子量为15.2 kDa,与理论纳米体序列的序列覆盖率为91 %。废培养基分析显示,与其他条件相比,在培养基中添加B+P的情况下,乙酸酯的产量较低。因此,B+P的补充可以在未来产生更多的质周纳米体。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Vitamin supplementation for enhanced production of therapeutic nanobody in E.coli
As low yields of nanobodies in E.coli. periplasm is a major concern for their large-scale production, this study explores the use of vitamins for enhanced production of a recombinant periplasmic nanobody product. Nanobody producing E.coli cells were cultivated in the modified Terrific-Broth supplemented with three different vitamins (biotin denoted as B, cyanocobalamin as C, and D-calcium pantothenate as P). Multiple combinations (B+P, B+C, P + C, and B+P + C) were examined, with B+P offering the highest specific growth rate, total biomass productivity, product accumulation and product expression. Densitometry analysis revealed 129.17 ± 1.1 mg/L nanobodies in case of B+P supplementation (24 % higher than control). B+P supplementation also offered 21 % better fermentation yield than control (as per RP-HPLC). The yield of purified nanobody product in case of B+P supplementation was at 35.0 ± 2.1 mg/L with purity levels of ≥ 80 %. Intact mass and peptide mapping analysis of purified nanobody revealed molecular weight of 15.2 kDa and 91 % sequence coverage with the theoretical nanobody sequence respectively. Spent media analysis revealed production of low acetate in case of B+P supplementation of media when compared to other conditions examined. Hence, the B+P supplementation could be used to produce improved amount of periplasmic nanobody in future.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Biochemical Engineering Journal
Biochemical Engineering Journal 工程技术-工程:化工
CiteScore
7.10
自引率
5.10%
发文量
380
审稿时长
34 days
期刊介绍: The Biochemical Engineering Journal aims to promote progress in the crucial chemical engineering aspects of the development of biological processes associated with everything from raw materials preparation to product recovery relevant to industries as diverse as medical/healthcare, industrial biotechnology, and environmental biotechnology. The Journal welcomes full length original research papers, short communications, and review papers* in the following research fields: Biocatalysis (enzyme or microbial) and biotransformations, including immobilized biocatalyst preparation and kinetics Biosensors and Biodevices including biofabrication and novel fuel cell development Bioseparations including scale-up and protein refolding/renaturation Environmental Bioengineering including bioconversion, bioremediation, and microbial fuel cells Bioreactor Systems including characterization, optimization and scale-up Bioresources and Biorefinery Engineering including biomass conversion, biofuels, bioenergy, and optimization Industrial Biotechnology including specialty chemicals, platform chemicals and neutraceuticals Biomaterials and Tissue Engineering including bioartificial organs, cell encapsulation, and controlled release Cell Culture Engineering (plant, animal or insect cells) including viral vectors, monoclonal antibodies, recombinant proteins, vaccines, and secondary metabolites Cell Therapies and Stem Cells including pluripotent, mesenchymal and hematopoietic stem cells; immunotherapies; tissue-specific differentiation; and cryopreservation Metabolic Engineering, Systems and Synthetic Biology including OMICS, bioinformatics, in silico biology, and metabolic flux analysis Protein Engineering including enzyme engineering and directed evolution.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信